生长抑素预防ERCP术后高淀粉酶血症及胰腺炎疗效的研究

doi:10.3969/j.issn.1007-3205.2020.11.008

河北医科大学学报 ›› 2020, Vol. 41 ›› Issue (11): 1276-1280.doi: 10.3969/j.issn.1007-3205.2020.11.008

生长抑素预防ERCP术后高淀粉酶血症及胰腺炎疗效的研究

1.河北省沧州市中心医院普外科内镜，河北沧州 061000；2.河北省沧州市人民医院疼痛科，河北沧州 061000；
3.河北省沧州市中心医院中医科，河北沧州 061000；4.河北省沧州市中心医院神经外科，河北沧州 061000

出版日期:2020-11-25 发布日期:2020-11-30
作者简介:张培建（1986-），男，河北河间人，河北省沧州市中心医院主治医师，医学硕士，从事外科疾病诊治研究。

Effect of somatostatin in preventing hyperamylase and post-ERCP pancreatitis

1.Department of General Surgery Endoscopy, Cangzhou Central Hospital, Hebei Province,
Cangzhou 061000, China; 2.Department of Pain Management, Cangzhou People′s Hospital,
Hebei Province, Cangzhou 061000, China; 3.Department of Traditional Chinese Medicine,
Cangzhou Central Hospital, Hebei Province, Cangzhou 061000, China; 4.Department of
Neurosurgery, Cangzhou Central Hospital, Hebei Province, Cangzhou 061000, China

Online:2020-11-25 Published:2020-11-30

摘要/Abstract

摘要： 目的探讨生长抑素预防性用药对内镜下逆行胰胆管造影术（endoscopic retrograde cholangiopancreatography，ERCP）术后高淀粉酶血症及ERCP术后胰腺炎（post -ERCP pancreatitis，PEP）的作用。
方法纳入拟行ERCP治疗的280例患者，以生长抑素250 μg/h持续应用24 h，依据不使用生长抑素，术前1 h、术后即刻、术后3 h采用随机数字表分为四组。检测术前及术后5 h、24 h的血淀粉酶水平，观察和比较术后高淀粉酶血症、PEP的发生情况。
结果 B、C、D组术后高淀粉酶血症和PEP发生率均显著低于A组，差异有统计学意义（P均＜0.05）。B、C、D组术后5 h、24 h血淀粉酶水平显著低于A组，差异有统计学意义（P＜0.05）。此外，B、C、D组间高淀粉酶血症、PEP发生率及术后血淀粉酶水平差异均无统计学意义（P＞0.05）。
结论预防性应用生长抑素可降低ERCP术后高淀粉酶血症及PEP的发生率，术前和术后3 h内用药的预防效果未见明显差别。

关键词: 胰腺炎, 生长抑素, 胰胆管造影术, 内窥镜逆行

Abstract: Objective To investigate the function of somatostatin prophylactic treatment in patients with postoperative hyperamylasemia and post ERCP pancreatitis(PEP) after endoscopic retrograde cholangiopancreatography(ERCP).
Methods A total of 280 patients to be treated with ERCP were included and treated with somatostatin 250 μg/h for 24 h. According to no use of somatostatin, they were divided into four groups by random number table 1 h before surgery, immediately after surgery, and 3 h after surgery.Serum amylase levels were detected 5 and 24 hours before and after operation, and the occurrence of postoperative hyperamylase and PEP were observed and compared.
Results There was no significant difference in age, sex and operation among the groups. The incidence of postoperative hyperamylasemia in group B, C and D was significantly lower than that in group A(P＜0.05). The incidence of PEP in group B, C and D was significantly lower than that in group A, with statistically significant differences(P＜0.05). Serum amylase levels in group B, C and D were significantly lower than those in group A 5 h and 24 h after surgery(P＜0.05). In addition, there were no significant differences in the incidence of hyperamylasemia, PEP and postoperative blood amylase levels among groups B, C and D(P＞0.05).
Conclusion The prophylactic application of somatostatin can reduce the incidence of hyperamylase and PEP after ERCP, and there was no significant difference in the prophylactic effect between preoperative and postoperative administration within 3 h.

Key words: pancreatitis, somatostatin, cholangiopancreatography, endoscopic retrograde

张培建, 刘孟东, 刘科霞, 王雅琪, 刘旭光. 生长抑素预防ERCP术后高淀粉酶血症及胰腺炎疗效的研究[J]. 河北医科大学学报, 2020, 41(11): 1276-1280.

ZHANG Pei-jian, LIU Meng-dong, LIU Ke-xia, WANG Ya-qi, LIU Xu-guang. Effect of somatostatin in preventing hyperamylase and post-ERCP pancreatitis[J]. Journal of Hebei Medical University, 2020, 41(11): 1276-1280.

[1]	张涛, 邹萍, 赵琦. 高脂血症胰腺炎患者血清血管紧张素转化酶2与巨噬细胞移动抑制因子水平检测及临床意义 [J]. 河北医科大学学报, 2023, 44(6): 724-728.
[2]	杜军卫, 靳君华. 急性胆源性胰腺炎发病危险因素分析 [J]. 河北医科大学学报, 2023, 44(12): 1448-1452.
[3]	曹荣来（综述）, 朱亮（审校）. 妊娠期胆胰疾病的ERCP诊疗进展 [J]. 河北医科大学学报, 2023, 44(10): 1227-1231.
[4]	陈圣雄, 范春艳, 李硕, 刘建华, 王文斌. 评价ERCP下单纯球囊扩张治疗十二指肠憩室旁乳头中等大小胆总管结石的临床效果[J]. 河北医科大学学报, 2021, 42(8): 956-959.
[5]	陈圣雄, 王文斌. 中国ERCP指南（2018版）解读[J]. 河北医科大学学报, 2021, 42(4): 373-375.
[6]	张培建, 刘孟东, 刘科霞, 王雅琪, 刘旭光. 生长抑素联合吲哚美辛栓剂降低胆管癌ERCP术后胰腺炎发生率的效果研究[J]. 河北医科大学学报, 2021, 42(3): 298-303.
[7]	张冰1，朱国玲2*，孙秋1，吉瑞更1. 开滦集团400例急性胰腺炎流行病学及危险因素分析[J]. 河北医科大学学报, 2020, 41(6): 723-727.
[8]	张健，刘贤，郭雅丽，李亚强，徐宝宏*. 甲磺酸加贝酯联合CBP治疗SAP的效果及对炎症“瀑布效应”相关因子的影响[J]. 河北医科大学学报, 2020, 41(3): 272-275,281.
[9]	何晨熙, 朱新影, 赵东强. 《2020国际共识：诊断性超声内镜在慢性胰腺炎管理中的作用》解读[J]. 河北医科大学学报, 2020, 41(12): 1365-1368.
[10]	米俊, 华鹏, 崔翔, 周荣赛. 免疫增强型肠内营养方案联合微创腹腔引流在重症急性胰腺炎中的临床应用[J]. 河北医科大学学报, 2020, 41(10): 1136-1139,1144.
[11]	纪晨光，赵东强. 《2018国际指南：慢性胰腺炎截面影像学诊断和严重程度评分》解读[J]. 河北医科大学学报, 2019, 40(5): 501-503.
[12]	聂立敏，段〓洁，赵〓瑞，刘艳霞，方艳伟*. 不同冲封管方式对胰腺炎患者留置鼻肠管通畅性的比较研究[J]. 河北医科大学学报, 2019, 40(5): 603-606.
[13]	陈圣雄1，郝子佳2，金〓成1，屈志刚3，段佳悦1，王文斌1*. ERCP在胃大部切除消化道重建毕Ⅱ术后胆总管结石患者的应用[J]. 河北医科大学学报, 2019, 40(4): 429-432.
[14]	李赛莲，许保，陈正义，黄晓曦，王齐全. 艾普拉唑联合生长抑素治疗重症急性胰腺炎的效果及安全性分析[J]. 河北医科大学学报, 2019, 40(11): 1261-1264.
[15]	陈永满，徐渭贤，孙立宝，董金明，赵晓波，周薇莉. 乌司他丁联用生长抑素治疗新生儿消化道畸形术后消化道出血的有效性与安全性评价[J]. 河北医科大学学报, 2017, 37(11): 1292-1294,1299.

生长抑素预防ERCP术后高淀粉酶血症及胰腺炎疗效的研究

Effect of somatostatin in preventing hyperamylase and post-ERCP pancreatitis

HTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价